Aileron Therapeutics Announces Positive Data From Cohort 1 of the Phase 1B Clinical Trial of Lti-03 in Idiopathic Pulmonary Fibrosis (Ipf)
Aileron Therapeutics公布了针对特发性肺纤维化(Ipf)的Lti-03的1B期临床试验队列1的阳性数据
Aileron Therapeutics Announces Positive Data From Cohort 1 of the Phase 1B Clinical Trial of Lti-03 in Idiopathic Pulmonary Fibrosis (Ipf)
Aileron Therapeutics公布了针对特发性肺纤维化(Ipf)的Lti-03的1B期临床试验队列1的阳性数据
使用浏览器的分享功能,分享给你的好友吧